Skip to main content
Clinical Trials/NL-OMON30360
NL-OMON30360
Recruiting
Not Applicable

Inflammation, excacerbation of heart failure, and ventricular tachyarrhythmias in stable heart failure patients with implantable cardioverter-defibrillator. - Biomarkers and ventricular tachyarrhythmias

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sudden cardiac death
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with a ClassI/Class II indication for ICD therapy
  • Patient with NYHA Class II and higher

Exclusion Criteria

  • Replacement of a pulsegenerator
  • Permanent atrial fibrillation
  • Life expectancy \< 1 year

Outcomes

Primary Outcomes

Not specified

Similar Trials